Charles Schwab Investment Management Inc Ocugen, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 860,244 shares of OCGN stock, worth $481,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares

860,244

Previous 766,956 12.16%

Holding current value

$481,736

Previous $759,000 9.35%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$0.72 - $1.08 $67,167 - $100,751	93,288 Added 12.16%	860,244 $688,000
Q3 2024 Nov 12, 2024	SELL	$0.98 - $1.95 $8,878 - $17,667	-9,060 Reduced 1.17%	766,956 $759,000
Q2 2024 Aug 12, 2024	BUY	$1.18 - $1.98 $714,799 - $1.2 Million	605,762 Added 355.8%	776,016 $1.2 Million
Q3 2023 Nov 08, 2023	SELL	$0.4 - $0.62 $385,506 - $597,534	-963,766 Reduced 84.99%	170,254 $68,000
Q2 2023 Aug 09, 2023	SELL	$0.45 - $0.88 $173,163 - $338,631	-384,808 Reduced 25.34%	1,134,020 $612,000
Q1 2023 May 11, 2023	SELL	$0.82 - $1.33 $83,211 - $134,965	-101,478 Reduced 6.26%	1,518,828 $1.29 Million
Q4 2022 Feb 13, 2023	BUY	$1.11 - $1.87 $68,626 - $115,614	61,826 Added 3.97%	1,620,306 $2.11 Million
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $62,728 - $111,119	35,845 Added 2.35%	1,558,480 $2.78 Million
Q2 2022 Aug 15, 2022	BUY	$1.83 - $3.45 $204,473 - $385,482	111,734 Added 7.92%	1,522,635 $3.46 Million
Q1 2022 May 13, 2022	BUY	$2.34 - $4.72 $92,837 - $187,261	39,674 Added 2.89%	1,410,901 $4.66 Million
Q4 2021 Feb 11, 2022	BUY	$4.38 - $15.67 $88,068 - $315,076	20,107 Added 1.49%	1,371,227 $6.24 Million
Q3 2021 Nov 16, 2021	BUY	$6.36 - $8.51 $5.62 Million - $7.52 Million	883,662 Added 189.04%	1,351,120 $9.7 Million
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $2.2 Million - $6.26 Million	399,181 Added 584.65%	467,458 $3.75 Million
Q1 2021 May 17, 2021	BUY	$1.66 - $15.81 $113,339 - $1.08 Million	68,277 New	68,277 $464,000

Others Institutions Holding OCGN

# of Institutions

123

Shares Held

68.6M

Call Options Held

478K

Put Options Held

253K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $121M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Ocugen, Inc. Transaction History